Published online Jun 30, 2019. doi: 10.13105/wjma.v7.i6.297
Peer-review started: April 23, 2019
First decision: May 24, 2019
Revised: May 31, 2019
Accepted: June 10, 2019
Article in press: June 10, 2019
Published online: June 30, 2019
Rumination syndrome (RS) is a relatively common yet underdiagnosed condition.
There is no consensus on how to treat patients diagnosed with runination syndrome.
Our objectives are to systematically review the literature on the efficacy of treatment options for adults with RS.
We conducted a systematic review according to PRISMA guidelines. We searched Medline (1946 to February 2019), EMBASE (1947 to February 2019), PsycINFO (1806 to February 2019) and Cochrane central register of controlled trials for articles discussing treatment options for adult patients (> 18 years) with RS. All relevant articles were accessed in full text. We extracted data on study designs, patient profiles, duration of symptoms, follow up periods, date, diagnostic criteria, interventions and outcomes. Risk of bias assessment was carried out independently by 3 reviewers via Cochrane Risk of Bias tool and Newcastle Ottawa Scale for RCTs and Cohort studies respectively.
12 articles were identified. The strongest evidence pointed towards diaphragmatic breathing (DB), and less so for baclofen. A total of 254 patients were included in the analysis.
DB has the strongest evidence for efficacy in adults with RS.
The quality of the evidence is still weak. More research needs to be done in this field.